100 related articles for article (PubMed ID: 12717423)
1. Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death.
Ko JK; Lee MJ; Cho SH; Cho JA; Lee BY; Koh JS; Lee SS; Shim YH; Kim CW
Oncogene; 2003 Apr; 22(16):2457-65. PubMed ID: 12717423
[TBL] [Abstract][Full Text] [Related]
2. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist.
Simmons MJ; Fan G; Zong WX; Degenhardt K; White E; Gélinas C
Oncogene; 2008 Feb; 27(10):1421-8. PubMed ID: 17724464
[TBL] [Abstract][Full Text] [Related]
3. MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain.
Bae J; Leo CP; Hsu SY; Hsueh AJ
J Biol Chem; 2000 Aug; 275(33):25255-61. PubMed ID: 10837489
[TBL] [Abstract][Full Text] [Related]
4. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members.
Hsu SY; Lin P; Hsueh AJ
Mol Endocrinol; 1998 Sep; 12(9):1432-40. PubMed ID: 9731710
[TBL] [Abstract][Full Text] [Related]
5. C-terminal region of Bfl-1 induces cell death that accompanies caspase activation when fused with GFP.
Yang WS; Ko JK; Park SO; Choi HY; Kim YN; Kim CW
J Cell Biochem; 2005 Apr; 94(6):1234-47. PubMed ID: 15696550
[TBL] [Abstract][Full Text] [Related]
6. Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor.
Kucharczak JF; Simmons MJ; Duckett CS; Gélinas C
Cell Death Differ; 2005 Sep; 12(9):1225-39. PubMed ID: 16094403
[TBL] [Abstract][Full Text] [Related]
7. Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities.
D'Sa-Eipper C; Chinnadurai G
Oncogene; 1998 Jun; 16(24):3105-14. PubMed ID: 9671389
[TBL] [Abstract][Full Text] [Related]
8. Conversion of Bfl-1, an anti-apoptotic Bcl-2 family protein, to a potent pro-apoptotic protein by fusion with green fluorescent protein (GFP).
Ko JK; Choi KH; Kim HJ; Choi HY; Yeo DJ; Park SO; Yang WS; Kim YN; Kim CW
FEBS Lett; 2003 Sep; 551(1-3):29-36. PubMed ID: 12965200
[TBL] [Abstract][Full Text] [Related]
9. The Bcl-2 family member Bfl-1/A1 is strongly repressed in normal and malignant plasma cells but is a potent anti-apoptotic factor for myeloma cells.
Tarte K; Jourdan M; Veyrune JL; Berberich I; Fiol G; Redal N; Shaughnessy J; Klein B
Br J Haematol; 2004 May; 125(3):373-82. PubMed ID: 15086420
[TBL] [Abstract][Full Text] [Related]
10. µ-Calpain conversion of antiapoptotic Bfl-1 (BCL2A1) into a prodeath factor reveals two distinct alpha-helices inducing mitochondria-mediated apoptosis.
Valero JG; Cornut-Thibaut A; Jugé R; Debaud AL; Giménez D; Gillet G; Bonnefoy-Bérard N; Salgado J; Salles G; Aouacheria A; Kucharczak J
PLoS One; 2012; 7(6):e38620. PubMed ID: 22745672
[TBL] [Abstract][Full Text] [Related]
11. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity.
D'Sa-Eipper C; Subramanian T; Chinnadurai G
Cancer Res; 1996 Sep; 56(17):3879-82. PubMed ID: 8752150
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bfl-1/A1 by siRNA inhibits mycobacterial growth in THP-1 cells by enhancing phagosomal acidification.
Dhiman R; Kathania M; Raje M; Majumdar S
Biochim Biophys Acta; 2008 Apr; 1780(4):733-42. PubMed ID: 18206119
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Bax-sigma, a cell death-inducing isoform of Bax.
Schmitt E; Paquet C; Beauchemin M; Dever-Bertrand J; Bertrand R
Biochem Biophys Res Commun; 2000 Apr; 270(3):868-79. PubMed ID: 10772918
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Bfl-1 protein expression sensitizes malignant B cells to apoptosis.
Brien G; Trescol-Biemont MC; Bonnefoy-Bérard N
Oncogene; 2007 Aug; 26(39):5828-32. PubMed ID: 17353899
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress attenuates Fas-mediated apoptosis in Jurkat T cell line through Bfl-1 induction.
Kim H; Kim YN; Kim H; Kim CW
Oncogene; 2005 Feb; 24(7):1252-61. PubMed ID: 15592513
[TBL] [Abstract][Full Text] [Related]
16. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.
Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M
ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line.
Kim JK; Kim KD; Lee E; Lim JS; Cho HJ; Yoon HK; Cho MY; Baek KE; Park YP; Paik SG; Choe YK; Lee HG
Cancer Lett; 2004 Aug; 212(1):61-70. PubMed ID: 15246562
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells.
Zhang H; Cowan-Jacob SW; Simonen M; Greenhalf W; Heim J; Meyhack B
J Biol Chem; 2000 Apr; 275(15):11092-9. PubMed ID: 10753914
[TBL] [Abstract][Full Text] [Related]
19. CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
Willimott S; Baou M; Naresh K; Wagner SD
Br J Haematol; 2007 Sep; 138(6):721-32. PubMed ID: 17760804
[TBL] [Abstract][Full Text] [Related]
20. Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins.
Zhai D; Jin C; Shiau CW; Kitada S; Satterthwait AC; Reed JC
Mol Cancer Ther; 2008 Jun; 7(6):1639-46. PubMed ID: 18566235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
